J0701 Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg

Short descriptor: Inj. cefepime hcl (baxter)

✓ Active HCPCS Level II 2026
Open J0701 in the app →

Look up J0701 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J0701 is the HCPCS Level II code for Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2024-01-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
cefepime hydrochloride, not therapeutically equivalent to maxipime
Dose / Unit
500 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J0701 with the canonical source and edition:

J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0701

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0701

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial